Preoperative Visitation Effect on Quality of Life of Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma.

Cancer diagnosis & prognosis Pub Date : 2025-03-03 eCollection Date: 2025-03-01 DOI:10.21873/cdp.10434
Toru Ishikawa, Atsuko Suzuki, Hiromi Yamamoto, Narumi Arita, Yusuke Matsuhashi, Nao Kobayashi, Eriko Nakagawa, Nanako Terai, Asami Hoshii, Terasu Honma
{"title":"Preoperative Visitation Effect on Quality of Life of Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma.","authors":"Toru Ishikawa, Atsuko Suzuki, Hiromi Yamamoto, Narumi Arita, Yusuke Matsuhashi, Nao Kobayashi, Eriko Nakagawa, Nanako Terai, Asami Hoshii, Terasu Honma","doi":"10.21873/cdp.10434","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>While transcatheter arterial chemoembolization (TACE) is a treatment option for patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma, it is associated with physical and psychological pain, with concerns regarding its effect on quality of life (QOL). In December 2020, we introduced radiology nurse-led preoperative visits to patients undergoing TACE. This study aimed to examine QOL improvement following a preoperative visit.</p><p><strong>Patients and methods: </strong>Among patients scheduled to undergo TACE for hepatocellular carcinoma, 48 received a preoperative visit and 22 did not (control group). We compared QOL variables between the groups using the Short-Form 36 (SF-36) at hospital admission and discharge.</p><p><strong>Results: </strong>No significant between-group differences in clinical backgrounds were observed. In the control group, SF-36 scores at admission/discharge were as follows: physical function (PF), 42.87±14.46/34.71±19.70 and mental health (MH), 51.32±8.67/45.26±11.35, respectively. In the subgroup analysis, the PF/MH item results were PF 40.89±14.55/31.46±19.25 and MH 51.10±9.07/44.79±12.04 for older adult patients in the control group. In the preoperative visit group, PF (admission, 42.31±14.23; discharge, 41.54±14.12; <i>p</i>=0.989) and MH (admission, 48.45±10.97; discharge, 49.59±10.05; <i>p</i>=0.399) were maintained.</p><p><strong>Conclusion: </strong>PF/MH items at admission and discharge were maintained or improved in the preoperative visit group, whereas those in the control group showed a significant decrease. Preoperative visits contributed to maintaining patient QOL.</p>","PeriodicalId":72510,"journal":{"name":"Cancer diagnosis & prognosis","volume":"5 2","pages":"230-237"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871864/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer diagnosis & prognosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21873/cdp.10434","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: While transcatheter arterial chemoembolization (TACE) is a treatment option for patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma, it is associated with physical and psychological pain, with concerns regarding its effect on quality of life (QOL). In December 2020, we introduced radiology nurse-led preoperative visits to patients undergoing TACE. This study aimed to examine QOL improvement following a preoperative visit.

Patients and methods: Among patients scheduled to undergo TACE for hepatocellular carcinoma, 48 received a preoperative visit and 22 did not (control group). We compared QOL variables between the groups using the Short-Form 36 (SF-36) at hospital admission and discharge.

Results: No significant between-group differences in clinical backgrounds were observed. In the control group, SF-36 scores at admission/discharge were as follows: physical function (PF), 42.87±14.46/34.71±19.70 and mental health (MH), 51.32±8.67/45.26±11.35, respectively. In the subgroup analysis, the PF/MH item results were PF 40.89±14.55/31.46±19.25 and MH 51.10±9.07/44.79±12.04 for older adult patients in the control group. In the preoperative visit group, PF (admission, 42.31±14.23; discharge, 41.54±14.12; p=0.989) and MH (admission, 48.45±10.97; discharge, 49.59±10.05; p=0.399) were maintained.

Conclusion: PF/MH items at admission and discharge were maintained or improved in the preoperative visit group, whereas those in the control group showed a significant decrease. Preoperative visits contributed to maintaining patient QOL.

术前探视对肝细胞癌经动脉化疗栓塞患者生活质量的影响。
背景/目的:虽然经导管动脉化疗栓塞(TACE)是巴塞罗那临床肝癌B期肝细胞癌患者的一种治疗选择,但它与身体和心理疼痛有关,并涉及其对生活质量(QOL)的影响。2020年12月,我们对接受TACE的患者引入了放射科护士主导的术前访问。本研究旨在检查术前访视后生活质量的改善情况。患者和方法:在计划接受肝细胞癌TACE治疗的患者中,48例接受术前访视,22例未接受术前访视(对照组)。我们使用短表36 (SF-36)在入院和出院时比较各组之间的生活质量变量。结果:两组患者临床背景无明显差异。对照组入院/出院时SF-36评分分别为身体功能(PF)(42.87±14.46/34.71±19.70)和心理健康(MH)(51.32±8.67/45.26±11.35)。在亚组分析中,对照组老年患者PF/MH项目得分分别为PF 40.89±14.55/31.46±19.25和MH 51.10±9.07/44.79±12.04。术前访视组PF(入院,42.31±14.23;放电,41.54±14.12;p=0.989)和MH(入院率48.45±10.97;放电,49.59±10.05;P =0.399)。结论:术前访视组患者入、出院时PF/MH指标维持或改善,对照组患者入、出院时PF/MH指标明显下降。术前访视有助于维持患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信